524.0500 29.45 (5.95%)
NSE Mar 02, 2026 15:42 PM
Volume: 279.6K
 

524.05
5.95%
ICICI Direct
company which is engaged into contract manufacturing of typical pharmaceutical products which later diversified into own manufacturing. Only few years ago it has started focusing on Oncology as dedicated and strategic business unit with vertically...
ICICI Direct released a Buy report for Sakar Healthcare Ltd. with a price target of 605.0 on 19 Feb, 2026.
More from Sakar Healthcare Ltd.
Recommended